These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7812011)

  • 1. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
    Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of posttransplantation lymphoproliferative disorders.
    Chadburn A; Cesarman E; Knowles DM
    Semin Diagn Pathol; 1997 Feb; 14(1):15-26. PubMed ID: 9044506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
    Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms.
    Chadburn A; Cesarman E; Liu YF; Addonizio L; Hsu D; Michler RE; Knowles DM
    Cancer; 1995 Jun; 75(11):2747-56. PubMed ID: 7743481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
    Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
    Orazi A; Hromas RA; Neiman RS; Greiner TC; Lee CH; Rubin L; Haskins S; Heerema NA; Gharpure V; Abonour R; Srour EF; Cornetta K
    Am J Clin Pathol; 1997 Apr; 107(4):419-29. PubMed ID: 9124210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.
    Nador RG; Chadburn A; Gundappa G; Cesarman E; Said JW; Knowles DM
    Am J Surg Pathol; 2003 Mar; 27(3):293-302. PubMed ID: 12604885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
    Frank D; Cesarman E; Liu YF; Michler RE; Knowles DM
    Blood; 1995 Mar; 85(5):1396-403. PubMed ID: 7858270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
    Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
    Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).
    Matolcsy A; Inghirami G; Knowles DM
    Blood; 1994 Mar; 83(5):1363-72. PubMed ID: 8118038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
    White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ
    J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
    Kingma DW; Shad A; Tsokos M; Fest T; Otsuki T; Frekko K; Werner E; Werner A; Magrath I; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1996 Dec; 20(12):1511-9. PubMed ID: 8944045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM
    Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
    Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.